Astera Labs (NASDAQ:ALAB) Research Coverage Started at Bank of America

Bank of America assumed coverage on shares of Astera Labs (NASDAQ:ALAB) in a research report sent to investors on Friday morning, MarketBeat reports. The brokerage issued a neutral rating and a $230.00 target price on the stock.

Other equities research analysts have also issued reports about the stock. Morgan Stanley raised their price objective on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a report on Friday, August 29th. Zacks Research raised Astera Labs to a “strong-buy” rating in a research note on Tuesday, August 12th. Needham & Company LLC boosted their price target on Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Barclays reaffirmed an “overweight” rating and set a $155.00 price objective (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Finally, Northland Capmk lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $159.83.

Astera Labs Price Performance

NASDAQ ALAB opened at $200.74 on Friday. Astera Labs has a one year low of $47.13 and a one year high of $262.90. The firm has a market cap of $33.37 billion, a P/E ratio of 358.46, a P/E/G ratio of 5.09 and a beta of 1.43. The stock’s 50-day moving average is $189.83 and its 200-day moving average is $119.85.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analysts’ expectations of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs’s revenue for the quarter was up 149.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts anticipate that Astera Labs will post 0.34 EPS for the current year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.02, for a total value of $47,605,600.00. Following the transaction, the chief operating officer directly owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. This represents a 4.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jitendra Mohan sold 152,517 shares of the firm’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the sale, the chief executive officer owned 450,001 shares of the company’s stock, valued at approximately $76,648,670.33. This represents a 25.31% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,492,036 shares of company stock valued at $232,607,552 in the last ninety days. Company insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

A number of large investors have recently made changes to their positions in ALAB. Great Valley Advisor Group Inc. lifted its holdings in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares during the last quarter. Straight Path Wealth Management grew its holdings in Astera Labs by 1.5% in the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after buying an additional 100 shares in the last quarter. First Horizon Advisors Inc. increased its position in Astera Labs by 12.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after buying an additional 108 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after buying an additional 194 shares in the last quarter. Finally, Hoey Investments Inc. boosted its position in shares of Astera Labs by 4.2% in the first quarter. Hoey Investments Inc. now owns 5,000 shares of the company’s stock valued at $298,000 after acquiring an additional 200 shares during the period. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.